Jennifer Carver, Chief Operating Officer at LA JOLLA PHARMACEUTICAL CO (LJPC), bought 4,000 shares at $6.19 ($25K) on 2019-01-09, disclosed to the SEC on 2019-01-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.15 | 1,000 | $6K | 24.9% |
| 2 | $6.16 | 1,000 | $6K | 25.0% |
| 3 | $6.17 | 1,000 | $6K | 25.0% |
| 4 | $6.19 | 484 | $3K | 12.1% |
| 5 | $6.19 | 516 | $3K | 12.9% |
| Total | $6.17 avg | 4,000 |
| $25K |
| 100% |
| Filing → |
| LJPC | BUY | 2017-12-29 | $33K | — | Filing → |
| LJPC | BUY | 2017-03-06 | $34K | — | Filing → |